As of January 22, 2025, Syros Pharmaceuticals (SYRS) has a market cap of $5.514 million USD. According to our data, Syros Pharmaceuticals is ranked No.9022 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $5.51 M |
-10.65%
|
Dec 31, 2024 | $6.17 M |
-97.05%
|
Dec 29, 2023 | $0.21 B |
116.99%
|
Dec 30, 2022 | $96.33 M |
-88.99%
|
Dec 31, 2021 | $0.87 B |
-69.95%
|
Dec 31, 2020 | $2.91 B |
57.02%
|
Dec 31, 2019 | $1.85 B |
24.06%
|
Dec 31, 2018 | $1.49 B |
-42.75%
|
Dec 29, 2017 | $2.61 B |
-19.98%
|
Dec 30, 2016 | $3.26 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Agios Pharmaceuticals
AGIO
|
$1.94 B |
-0.000 M
|
USA
|
Kura Oncology
KURA
|
$0.61 B |
0.000 M
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Relay Therapeutics
RLAY
|
$0.82 B |
0.000 M
|
USA
|
Revolution Medicines
RVMD
|
$7.56 B |
0.000 M
|
USA
|
Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
USA
|
G1 Therapeutics
GTHX
|
$0.38 B |
0.000 M
|
USA
|
Zymeworks
ZYME
|
$1.01 B |
-0.000 M
|
Canada
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Arcus Biosciences
RCUS
|
$1.23 B |
-0.000 M
|
USA
|
Market Cap | = | SYRS Stock Price | * | SYRS Shares Outstanding |
= | $0.21 | * | 26.83 M | |
= | $5.51 M |